A Hiroshima University researcher contends that Japan's newly enacted law regulating human genome-edited embryos and germ ...
A Hiroshima University researcher outlines advantages of Japan's new law that prohibits the transfer of genome-edited human ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance laying out its proposed regulatory approach to ...
Delivering a compact CRISPR, "psCas12f," which can be turned on and off with light, via a single AAV, and performing genome ...
Capitalize on ready-to-use CRISPR kits & enzymes and drug discovery demand with competitive insights, untapped market analysis, and go-to-market strategies.Dublin, Oct. (GLOBE NEWSWIRE) -- "CRISPR ...
The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing editing ...
A systematic bibliometric analysis of 25 years of Ficus literature shows that only about 11.3 percent of publications address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results